Skip to main content
. 2018 Aug 13;139(1):89–96. doi: 10.1111/acps.12948

Table 3.

Prevalence of cADHD and/or aADHD symptomatology reported by patients with SCZ in the UCL genetics of schizophrenia cohort

Lifetime ADHD symptomatology Freq: (N = 126) Per cent (%) Age range Gender N (%) male
c+aADHD 29 23.0 23–77 19 (65.5)
aADHD only 16 12.7 35–70 10 (62.5)
cADHD only 14 11.1 29–65 9 (64.3)
No ADHD 67 53.2 21–85 45 (67.2)

cADHD, childhood ADHD symptomatology; aADHD, adulthood ADHD symptomatology; c+aADHD, child and adulthood ADHD symptomatology.